시장보고서
상품코드
1467249

세계의 생물학적 안전 캐비닛 시장

Biological Safety Cabinets

발행일: | 리서치사: Global Industry Analysts, Inc. | 페이지 정보: 영문 194 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    


※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

생물학적 안전 캐비닛 세계 시장은 2030년까지 3억 1,880만 달러에 달할 전망

2023년 2억 1,360만 달러로 추정되는 생물학적 안전 캐비닛 세계 시장은 2023년부터 2030년까지 연평균 5.1% 성장하여 2030년에는 3억 1,880만 달러에 달할 것으로 예상됩니다. 이 보고서에서 분석한 부문 중 하나인 클래스 I 생물학적 안전 캐비닛은 CAGR 5%를 기록하여 분석 기간 종료 시점에 1억 1,100만 달러에 도달할 것으로 예상됩니다. 클래스 II 생물학적 안전 캐비닛 부문은 향후 8년간 5.6%의 CAGR을 기록할 것으로 예상됩니다.

미국 시장 6,330만 달러, 중국은 CAGR 4.8%로 성장 전망

미국의 생물학적 안전 캐비닛 시장은 2023년에 6,330만 달러에 달할 것으로 추정됩니다. 세계 2위의 경제 대국인 중국은 2023년부터 2030년까지 분석 기간 동안 연평균 4.8%의 성장률을 보이며 2030년까지 5,580만 달러의 시장 규모에 도달할 것으로 예상됩니다. 다른 주목할 만한 지역 시장으로는 일본과 캐나다가 2023년부터 2030년까지 각각 4.6%와 4.2%의 성장률을 보일 것으로 예측됩니다. 유럽에서는 독일이 연평균 약 3.9%의 성장률을 보일 것으로 예상됩니다.

2024년을 향한 새로운 보고 기능을 소개

인플루언서 인게이지먼트 통계에 대한 전체 액세스 권한

디지털 아카이브와 'MarketGlass' 리서치 플랫폼에 무료로 액세스할 수 있습니다. MarketGlass 플랫폼은 전 세계 전문가들의 창의성과 시장 지식을 통합적이고 협력적으로 활용할 수 있도록 지원합니다. 당사의 최첨단 도구는 시장 진입자의 프라이버시와 신원을 보호하면서 세계적 수준의 시장 전망을 제공합니다. 보고서의 수치, 통계 및 시장 설명은 이 분야의 전문가와 영향력 있는 사람들이 공유한 엄선된 인사이트를 기반으로 합니다.

실시간 데이터 시뮬레이터 도구와 맞춤형 보고서 작성 기능을 갖춘 인터랙티브 설문 조사에 참여할 수 있는 기회

기업 간 스마트한 의견 교환을 위한 피어 콜라보레이션 인터랙티브 플랫폼에 대한 풀 클라이언트 액세스

1년간 무료 보고서 업데이트

주요 기업의 세계 시장 점유율을 포함한 경쟁사 커버리지

여러 지역에 걸친 기업의 시장 입지 분석(강세/활기찬/ 틈새/소규모)

전문가/인플루언서 인터뷰, 팟캐스트, 보도 자료, 행사 기조연설 유튜브 동영상에 대한 접근성

2024년 세계 경제에 기대하는 것들

통화 긴축과 이에 따른 금리 상승으로 인한 지정학적, 경제적 불안정성이 2024년에도 격변의 시기를 만들어 낼 것으로 보입니다. 중동의 적대 행위와 점점 더 잦아지는 기후 재해 등 여러 요인들이 경기 회복에 대한 압력을 계속 가할 것으로 보입니다. 위험요인이 있는 반면, 디플레이션의 조짐이 강해지고, 완고한 인플레이션에 대한 불안감이 완화되고, 공급망이 정상화되고, 에너지 비용의 변동에도 불구하고 물가가 완만하게 상승하는 등 몇 가지 긍정적인 요소도 나타나고 있습니다. 인도와 미국을 비롯한 G21 국가들의 선거는 자본 흐름과 투자 전략에 영향을 미칠 수 있습니다. 인도가 세계 투자처로 주목받고 있는 가운데, 미국에 기반을 둔 하이테크 기업들은 역동적인 인재와 자본 생태계에 힘입어 계속 우위를 점할 것으로 보입니다. 실리콘밸리를 비롯한 기술 기회는 미국 경제의 둔화에도 불구하고 여전히 견고하고, 규제 환경이 잘 정비되어 있어 높은 성장 잠재력을 추구하는 투자자들에게 여전히 매력적일 것으로 보입니다. 유럽은 긴축정책과 경기침체 리스크와의 싸움이 계속되고 있지만, 영국은 2024년 경기침체 리스크가 가장 높은 국가로 전망이 가장 어둡습니다. 중국은 정부 지출과 개인 소비의 개선에 힘입어 성장세를 이어갈 것으로 기대되는 반면, 불확실성이 지속될 것으로 보입니다. 불안정한 환경은 투자자와 기업 모두에게 기회와 도전을 동시에 가져다 줄 것으로 보입니다. 변동성을 성장의 촉매제로 받아들이고, 민첩성과 전략적 선견지명을 가지고 투자 결정을 내리는 것이 생존을 위해 중요하다는 점은 변함이 없습니다.

조사 대상 기업 예시

  • Air Science LLC
  • Berner International
  • BIOBASE
  • Cruma-Diantech Solutions S.L.
  • Esco Micro Pte.
  • Euroclone S.p.A.
  • Germfree
  • Kewaunee Scientific Corporation
  • Labconco Corporaton
  • NuAire, Inc.
  • The Baker Company, Inc.
  • Thermo Fisher Scientific, Inc.

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 성장 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 기타 유럽
  • 아시아태평양
  • 세계 기타 지역

제4장 경쟁

ksm 24.05.09

Global Biological Safety Cabinets Market to Reach $318.8 Million by 2030

The global market for Biological Safety Cabinets estimated at US$213.6 Million in the year 2023, is expected to reach US$318.8 Million by 2030, growing at a CAGR of 5.1% over the period 2023-2030. Class I Biological Safety Cabinets, one of the segments analyzed in the report, is expected to record 5% CAGR and reach US$111 Million by the end of the analysis period. Growth in the Class II Biological Safety Cabinets segment is estimated at 5.6% CAGR for the next 8-year period.

The U.S. Market is Estimated at $63.3 Million, While China is Forecast to Grow at 4.8% CAGR

The Biological Safety Cabinets market in the U.S. is estimated at US$63.3 Million in the year 2023. China, the world`s second largest economy, is forecast to reach a projected market size of US$55.8 Million by the year 2030 trailing a CAGR of 4.8% over the analysis period 2023 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4.6% and 4.2% respectively over the 2023-2030 period. Within Europe, Germany is forecast to grow at approximately 3.9% CAGR.

Introducing Our Exciting New Report Features for 2024

Full access to influencer engagement stats

Free access to our digital archives & "MarketGlass" research platform. Our proprietary MarketGlass platform is fully enabled to unlock creativity and market knowledge of domain experts worldwide in a cohesive and collaborative manner. Our state-of-art tools bring world class market perspectives while protecting participants` privacy and identity. Numbers, statistics and market narrative in the report are based on fully curated insights shared by domain experts and influencers in this space.

Opportunity to engage with interactive questionnaires that come with real-time data simulator tools & bespoke report generation capabilities

Full client access to peer collaborative and interactive platform for cross-enterprise smart exchange of ideas

Complimentary report updates for one year

Competitor coverage with global market shares of major players

Player market presence analysis (Strong/Active/Niche/Trivial) across multiple geographies

Access to curated YouTube video transcripts of domain experts/influencer interviews, podcasts, press statements and event keynotes

What to Expect from the Global Economy in 2024

Edgy geopolitics, and economic instability caused by monetary policy tightening and ensuing higher interest rates will create a tumultuous landscape for 2024. Several factors will continue to exert pressure on the path to recovery including hostilities in the Middle East and increasingly common climate disasters. Among the risks, several positives are also taking shape such as growing signs of disinflation and easing of anxiety over stubborn inflation, supply chain normalization and price moderation despite volatility in energy costs. Elections across several G21 jurisdictions, notably in India and the United States, will have potential ramifications for capital flows and investment strategies. While India emerges as a compelling destination in the global investment landscape, U.S, based tech firms will continue to dominate, fueled by a dynamic ecosystem of talent and capital. Tech opportunities in Silicon Valley and beyond remain attractive for investors seeking high-growth prospects supported largely by a resilient albeit slowing domestic economy and conducive regulatory environment. Europe will continue to battle tight monetary policy and recession risks with U.K. having the most challenging outlook and running the greatest risk of recession in 2024. China remains a wild card with hope for growth in the country underpinned by government spending and improvements in consumer spending. The volatile environment will offer both opportunities and challenges for investors and businesses alike. Embracing volatility as a catalyst for growth together with agility and strategic foresight in navigating investment decisions will remain important for survival.

Select Competitors (Total 42 Featured) -

  • Air Science LLC
  • Berner International
  • BIOBASE
  • Cruma - Diantech Solutions S.L.
  • Esco Micro Pte. Ltd.
  • Euroclone S.p.A.
  • Germfree
  • Kewaunee Scientific Corporation
  • Labconco Corporaton
  • NuAire, Inc.
  • The Baker Company, Inc.
  • Thermo Fisher Scientific, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Biological Safety Cabinet to Register Steady Growth
    • Class II Biological Safety Cabinets to Account for Highest Growth, Driven by Higher Level of Protection
    • A Brief Description of Class I, Class II, and Class III Biological Safety Cabinets
    • By End-User Segment, Pharmaceutical & Biopharmaceutical Companies to Register Largest Growth
    • Market Share of Biological Safety Cabinet by End-User Type
    • Biological Safety Cabinets - Global Key Competitors Percentage Market Share in 2022 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
    • Global Economic Update
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Emergence of Various Communicable Diseases to Bode Well for Market Demand
    • Breakdown of Total Number of Diseases Reported by Disease Variety: 1980 to 2010
    • Total Number of Disease Cases from Fleas, Ticks, and Mosquitoes in the US: 2004 to 2016
    • Innovations to Support Market Growth
    • Spur in R&D Activities to Bode Well for Market Growth
    • Total Worldwide Spending (in Billion USD) on Pharmaceutical R&D: 2010 to 2024
    • Availability of Alternatives to Biological Safety Cabinets to Deter Market Growth
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Biological Safety Cabinets by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Biological Safety Cabinets by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 3: World 16-Year Perspective for Biological Safety Cabinets by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Class I by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Class I by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 6: World 16-Year Perspective for Class I by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Class II by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Class II by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 9: World 16-Year Perspective for Class II by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Class III by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Class III by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 12: World 16-Year Perspective for Class III by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Diagnostic & Testing Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Diagnostic & Testing Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 15: World 16-Year Perspective for Diagnostic & Testing Laboratories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Academic & Research Institution by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Academic & Research Institution by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 18: World 16-Year Perspective for Academic & Research Institution by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 19: World Biological Safety Cabinets Market Analysis of Annual Sales in US$ for Years 2014 through 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Pharma & Biopharma Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Pharma & Biopharma Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 22: World 16-Year Perspective for Pharma & Biopharma Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Biological Safety Cabinets Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 23: USA Recent Past, Current & Future Analysis for Biological Safety Cabinets by Type - Class I, Class II and Class III - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Biological Safety Cabinets by Type - Class I, Class II and Class III Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 25: USA 16-Year Perspective for Biological Safety Cabinets by Type - Percentage Breakdown of Value Sales for Class I, Class II and Class III for the Years 2014, 2024 & 2030
    • TABLE 26: USA Recent Past, Current & Future Analysis for Biological Safety Cabinets by End-Use - Pharma & Biopharma Companies, Diagnostic & Testing Laboratories and Academic & Research Institution - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Biological Safety Cabinets by End-Use - Pharma & Biopharma Companies, Diagnostic & Testing Laboratories and Academic & Research Institution Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 28: USA 16-Year Perspective for Biological Safety Cabinets by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies, Diagnostic & Testing Laboratories and Academic & Research Institution for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Biological Safety Cabinets by Type - Class I, Class II and Class III - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Biological Safety Cabinets by Type - Class I, Class II and Class III Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 31: Canada 16-Year Perspective for Biological Safety Cabinets by Type - Percentage Breakdown of Value Sales for Class I, Class II and Class III for the Years 2014, 2024 & 2030
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Biological Safety Cabinets by End-Use - Pharma & Biopharma Companies, Diagnostic & Testing Laboratories and Academic & Research Institution - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Biological Safety Cabinets by End-Use - Pharma & Biopharma Companies, Diagnostic & Testing Laboratories and Academic & Research Institution Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 34: Canada 16-Year Perspective for Biological Safety Cabinets by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies, Diagnostic & Testing Laboratories and Academic & Research Institution for the Years 2014, 2024 & 2030
  • JAPAN
    • Biological Safety Cabinets Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Biological Safety Cabinets by Type - Class I, Class II and Class III - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Biological Safety Cabinets by Type - Class I, Class II and Class III Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 37: Japan 16-Year Perspective for Biological Safety Cabinets by Type - Percentage Breakdown of Value Sales for Class I, Class II and Class III for the Years 2014, 2024 & 2030
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Biological Safety Cabinets by End-Use - Pharma & Biopharma Companies, Diagnostic & Testing Laboratories and Academic & Research Institution - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Biological Safety Cabinets by End-Use - Pharma & Biopharma Companies, Diagnostic & Testing Laboratories and Academic & Research Institution Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 40: Japan 16-Year Perspective for Biological Safety Cabinets by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies, Diagnostic & Testing Laboratories and Academic & Research Institution for the Years 2014, 2024 & 2030
  • CHINA
    • Biological Safety Cabinets Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 41: China Recent Past, Current & Future Analysis for Biological Safety Cabinets by Type - Class I, Class II and Class III - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Biological Safety Cabinets by Type - Class I, Class II and Class III Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 43: China 16-Year Perspective for Biological Safety Cabinets by Type - Percentage Breakdown of Value Sales for Class I, Class II and Class III for the Years 2014, 2024 & 2030
    • TABLE 44: China Recent Past, Current & Future Analysis for Biological Safety Cabinets by End-Use - Pharma & Biopharma Companies, Diagnostic & Testing Laboratories and Academic & Research Institution - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Biological Safety Cabinets by End-Use - Pharma & Biopharma Companies, Diagnostic & Testing Laboratories and Academic & Research Institution Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 46: China 16-Year Perspective for Biological Safety Cabinets by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies, Diagnostic & Testing Laboratories and Academic & Research Institution for the Years 2014, 2024 & 2030
  • EUROPE
    • Biological Safety Cabinets Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Biological Safety Cabinets by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Biological Safety Cabinets by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 49: Europe 16-Year Perspective for Biological Safety Cabinets by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Biological Safety Cabinets by Type - Class I, Class II and Class III - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Biological Safety Cabinets by Type - Class I, Class II and Class III Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 52: Europe 16-Year Perspective for Biological Safety Cabinets by Type - Percentage Breakdown of Value Sales for Class I, Class II and Class III for the Years 2014, 2024 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Biological Safety Cabinets by End-Use - Pharma & Biopharma Companies, Diagnostic & Testing Laboratories and Academic & Research Institution - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Biological Safety Cabinets by End-Use - Pharma & Biopharma Companies, Diagnostic & Testing Laboratories and Academic & Research Institution Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 55: Europe 16-Year Perspective for Biological Safety Cabinets by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies, Diagnostic & Testing Laboratories and Academic & Research Institution for the Years 2014, 2024 & 2030
  • FRANCE
    • Biological Safety Cabinets Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 56: France Recent Past, Current & Future Analysis for Biological Safety Cabinets by Type - Class I, Class II and Class III - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Biological Safety Cabinets by Type - Class I, Class II and Class III Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 58: France 16-Year Perspective for Biological Safety Cabinets by Type - Percentage Breakdown of Value Sales for Class I, Class II and Class III for the Years 2014, 2024 & 2030
    • TABLE 59: France Recent Past, Current & Future Analysis for Biological Safety Cabinets by End-Use - Pharma & Biopharma Companies, Diagnostic & Testing Laboratories and Academic & Research Institution - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Biological Safety Cabinets by End-Use - Pharma & Biopharma Companies, Diagnostic & Testing Laboratories and Academic & Research Institution Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 61: France 16-Year Perspective for Biological Safety Cabinets by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies, Diagnostic & Testing Laboratories and Academic & Research Institution for the Years 2014, 2024 & 2030
  • GERMANY
    • Biological Safety Cabinets Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Biological Safety Cabinets by Type - Class I, Class II and Class III - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Biological Safety Cabinets by Type - Class I, Class II and Class III Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 64: Germany 16-Year Perspective for Biological Safety Cabinets by Type - Percentage Breakdown of Value Sales for Class I, Class II and Class III for the Years 2014, 2024 & 2030
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Biological Safety Cabinets by End-Use - Pharma & Biopharma Companies, Diagnostic & Testing Laboratories and Academic & Research Institution - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Biological Safety Cabinets by End-Use - Pharma & Biopharma Companies, Diagnostic & Testing Laboratories and Academic & Research Institution Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 67: Germany 16-Year Perspective for Biological Safety Cabinets by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies, Diagnostic & Testing Laboratories and Academic & Research Institution for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Biological Safety Cabinets by Type - Class I, Class II and Class III - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Biological Safety Cabinets by Type - Class I, Class II and Class III Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 70: Italy 16-Year Perspective for Biological Safety Cabinets by Type - Percentage Breakdown of Value Sales for Class I, Class II and Class III for the Years 2014, 2024 & 2030
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Biological Safety Cabinets by End-Use - Pharma & Biopharma Companies, Diagnostic & Testing Laboratories and Academic & Research Institution - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Biological Safety Cabinets by End-Use - Pharma & Biopharma Companies, Diagnostic & Testing Laboratories and Academic & Research Institution Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 73: Italy 16-Year Perspective for Biological Safety Cabinets by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies, Diagnostic & Testing Laboratories and Academic & Research Institution for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Biological Safety Cabinets Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 74: UK Recent Past, Current & Future Analysis for Biological Safety Cabinets by Type - Class I, Class II and Class III - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Biological Safety Cabinets by Type - Class I, Class II and Class III Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 76: UK 16-Year Perspective for Biological Safety Cabinets by Type - Percentage Breakdown of Value Sales for Class I, Class II and Class III for the Years 2014, 2024 & 2030
    • TABLE 77: UK Recent Past, Current & Future Analysis for Biological Safety Cabinets by End-Use - Pharma & Biopharma Companies, Diagnostic & Testing Laboratories and Academic & Research Institution - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Biological Safety Cabinets by End-Use - Pharma & Biopharma Companies, Diagnostic & Testing Laboratories and Academic & Research Institution Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 79: UK 16-Year Perspective for Biological Safety Cabinets by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies, Diagnostic & Testing Laboratories and Academic & Research Institution for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 80: Rest of Europe Recent Past, Current & Future Analysis for Biological Safety Cabinets by Type - Class I, Class II and Class III - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Rest of Europe Historic Review for Biological Safety Cabinets by Type - Class I, Class II and Class III Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 82: Rest of Europe 16-Year Perspective for Biological Safety Cabinets by Type - Percentage Breakdown of Value Sales for Class I, Class II and Class III for the Years 2014, 2024 & 2030
    • TABLE 83: Rest of Europe Recent Past, Current & Future Analysis for Biological Safety Cabinets by End-Use - Pharma & Biopharma Companies, Diagnostic & Testing Laboratories and Academic & Research Institution - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Rest of Europe Historic Review for Biological Safety Cabinets by End-Use - Pharma & Biopharma Companies, Diagnostic & Testing Laboratories and Academic & Research Institution Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 85: Rest of Europe 16-Year Perspective for Biological Safety Cabinets by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies, Diagnostic & Testing Laboratories and Academic & Research Institution for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Biological Safety Cabinets Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 86: Asia-Pacific Recent Past, Current & Future Analysis for Biological Safety Cabinets by Type - Class I, Class II and Class III - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Asia-Pacific Historic Review for Biological Safety Cabinets by Type - Class I, Class II and Class III Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 88: Asia-Pacific 16-Year Perspective for Biological Safety Cabinets by Type - Percentage Breakdown of Value Sales for Class I, Class II and Class III for the Years 2014, 2024 & 2030
    • TABLE 89: Asia-Pacific Recent Past, Current & Future Analysis for Biological Safety Cabinets by End-Use - Pharma & Biopharma Companies, Diagnostic & Testing Laboratories and Academic & Research Institution - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Asia-Pacific Historic Review for Biological Safety Cabinets by End-Use - Pharma & Biopharma Companies, Diagnostic & Testing Laboratories and Academic & Research Institution Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 91: Asia-Pacific 16-Year Perspective for Biological Safety Cabinets by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies, Diagnostic & Testing Laboratories and Academic & Research Institution for the Years 2014, 2024 & 2030
  • REST OF WORLD
    • TABLE 92: Rest of World Recent Past, Current & Future Analysis for Biological Safety Cabinets by Type - Class I, Class II and Class III - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Rest of World Historic Review for Biological Safety Cabinets by Type - Class I, Class II and Class III Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 94: Rest of World 16-Year Perspective for Biological Safety Cabinets by Type - Percentage Breakdown of Value Sales for Class I, Class II and Class III for the Years 2014, 2024 & 2030
    • TABLE 95: Rest of World Recent Past, Current & Future Analysis for Biological Safety Cabinets by End-Use - Pharma & Biopharma Companies, Diagnostic & Testing Laboratories and Academic & Research Institution - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Rest of World Historic Review for Biological Safety Cabinets by End-Use - Pharma & Biopharma Companies, Diagnostic & Testing Laboratories and Academic & Research Institution Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 97: Rest of World 16-Year Perspective for Biological Safety Cabinets by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies, Diagnostic & Testing Laboratories and Academic & Research Institution for the Years 2014, 2024 & 2030

IV. COMPETITION

비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제